SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001804591-24-000059
Filing Date
2024-11-12
Accepted
2024-11-12 07:41:07
Documents
96
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q me-20240930.htm   iXBRL 10-Q 1934257
2 EX-31.1 me-20240930xex311.htm EX-31.1 10802
3 EX-31.2 me-20240930xex312.htm EX-31.2 10801
4 EX-32.1 me-20240930xex321.htm EX-32.1 5147
5 EX-32.2 me-20240930xex322.htm EX-32.2 5426
  Complete submission text file 0001804591-24-000059.txt   10389208

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT me-20240930.xsd EX-101.SCH 69131
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT me-20240930_cal.xml EX-101.CAL 81560
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT me-20240930_def.xml EX-101.DEF 433313
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT me-20240930_lab.xml EX-101.LAB 822987
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT me-20240930_pre.xml EX-101.PRE 625603
99 EXTRACTED XBRL INSTANCE DOCUMENT me-20240930_htm.xml XML 1706159
Mailing Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086
Business Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-39587 | Film No.: 241443365
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)